Mabtas RA 500 Injection 50 ml contains Rituximab, which belongs to the class of monoclonal antibodies. It works by inhibiting the DNA and RNA transcription that is essential for cancer cell growth. This helps prevent the growth and further spread of cancerous or non-cancerous cells. On the other hand, Mabtas RA 500 Injection 50 ml works by interfering with the immune system process that causes inflammation in the joint tissues. Thus, it reduces pain and inflammation and prevents joint damage and disease progression over time.

FAQs

How does Mabtas RA 500 Injection 50 ml work?

Mabtas RA 500 Injection 50 ml contains Rituximab, which works by inhibiting the DNA and RNA transcription that is essential for cancer cell growth.

What are the conditions to be noted while receiving Mabtas RA 500 Injection 50 ml?

Mabtas RA 500 Injection 50 ml may cause bowel obstruction and perforation, reactivation of Hepatitis B infection, Cardiac arrhythmias, tumour lysis syndrome, and angina in some patients. Hence, inform your oncologist about your complete medical history, including current medication, to rule out any side effects/interactions.